Capital International Ltd. CA Reduces Stock Position in Danaher Corporation $DHR

Capital International Ltd. CA trimmed its position in Danaher Corporation (NYSE:DHR) by 30.3% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 43,590 shares of the conglomerate’s stock after selling 18,925 shares during the period. Capital International Ltd. CA’s holdings in Danaher were worth $8,642,000 as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of DHR. WFA of San Diego LLC purchased a new position in Danaher during the second quarter valued at approximately $26,000. Howard Hughes Medical Institute bought a new stake in Danaher in the 2nd quarter worth approximately $27,000. ANTIPODES PARTNERS Ltd bought a new stake in shares of Danaher in the 3rd quarter worth about $27,000. TruNorth Capital Management LLC purchased a new stake in Danaher during the third quarter valued at approximately $28,000. Finally, Tripletail Wealth Management LLC purchased a new position in Danaher during the third quarter worth $31,000. Institutional investors own 79.05% of the company’s stock.

Danaher Stock Up 1.7%

DHR stock opened at $198.85 on Tuesday. Danaher Corporation has a one year low of $171.00 and a one year high of $242.80. The firm has a market cap of $140.62 billion, a PE ratio of 39.45, a PEG ratio of 2.64 and a beta of 0.93. The firm’s 50 day moving average price is $221.89 and its 200-day moving average price is $215.95. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.51 and a current ratio of 1.87.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share for the quarter, beating the consensus estimate of $2.14 by $0.09. The company had revenue of $6.84 billion during the quarter, compared to the consensus estimate of $6.79 billion. Danaher had a return on equity of 10.81% and a net margin of 14.71%.Danaher’s revenue was up 4.6% compared to the same quarter last year. During the same period in the previous year, the company posted $2.14 EPS. On average, equities research analysts anticipate that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Friday, March 27th will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 0.8%. The ex-dividend date is Friday, March 27th. This is an increase from Danaher’s previous quarterly dividend of $0.32. Danaher’s payout ratio is presently 25.40%.

Insider Activity

In other news, EVP Gregory M. Milosevich sold 1,320 shares of Danaher stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $208.01, for a total transaction of $274,573.20. Following the completion of the transaction, the executive vice president owned 5,099 shares of the company’s stock, valued at $1,060,642.99. The trade was a 20.56% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Insiders own 11.20% of the company’s stock.

Analysts Set New Price Targets

Several analysts have recently weighed in on the company. Leerink Partners lifted their target price on Danaher from $260.00 to $270.00 and gave the stock an “outperform” rating in a research report on Friday, January 16th. Morgan Stanley initiated coverage on shares of Danaher in a report on Monday, December 1st. They issued an “overweight” rating and a $270.00 price target on the stock. Evercore restated an “outperform” rating and set a $254.00 target price on shares of Danaher in a research note on Wednesday, January 28th. Guggenheim boosted their price objective on shares of Danaher from $250.00 to $275.00 and gave the company a “buy” rating in a report on Friday, January 2nd. Finally, Wells Fargo & Company lifted their price objective on shares of Danaher from $230.00 to $240.00 and gave the company an “equal weight” rating in a research note on Monday, December 15th. Twenty analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Danaher currently has a consensus rating of “Moderate Buy” and a consensus target price of $253.86.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.